Clinical trial
The Use of Tx360™ Nasal Applicator for Sphenopalatine Ganglion Block in the Treatment of Trigeminal Neuralgia
NCT01761604 is registered in ClinicalTrials.gov with Chicago Anesthesia Pain Specialists as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Tx360™ Nasal Applicator for Sphenopalatine Ganglion Block in the Treatment of Trigeminal Neuralgia
- Lead sponsor
- Chicago Anesthesia Pain Specialists
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2011
- Completion date
- September 30, 2017
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.